From Editor-in-Chief
Kan Chiba, Ph.D.
Graduate School of Pharmaceutical Sciences, Chiba University
It is with
great honor to be named as the successor of Dr. Masahiro Hayashi,
the editor-in-chief of our society journal, ‘Drug Metabolism and
Pharmacokinetics(DMPK).
DMPK was launched in 2002 as the replacement of our formal society
journal, ‘Xenobiotic Metabolism and Disposition’. It has been
transformed, starting with the cover design, to its current style
as an English journal by the great efforts of Dr. Hayashi. I feel
that it is my responsibility to continue in his achievements,
as well as to take part in DMPK’ s further growth as an international
journal.
Presently, the globalization of the pharmaceutical field is rapidly
growing, and communication in the English language is a necessity.
It is my great challenge to create the basis of making DMPK, the
journal to be acknowledged internationally, specializing in the
field of xenobiotic metabolism and disposition. With the efforts
of Dr. Hayashi and the committee, DMPK is now entered in PubMed,
have taken steps to achieve impact factors, and will be starting
the testing of the electronic submission system.
My first important job is to have the submission system working,
and to have more researchers from overseas, submitting their manuscripts
to our journal. In order to do so, I would like to welcome more
Associate Editors from the Asian Pacific areas, such as from Korea,
Taiwan, Singapore, and Australia, where we expect more submissions
in the near future. Also, I would like to actively appeal the
quality of DMPK at the international meetings, and let it be widely
known.
I welcome any opinions and requests from all members of the society,
it is my great wish to make DMPK, a familiar journal to all readers.
As the former editor-in-chief Dr. Hayashi has always said, “Please
love DMPK”. The editors of DMPK are eager to have DMPK read worldwide,
and at the same time, have the readers feel at-home. Your continued
support will be greatly appreciated.